Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

5.0K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
5.0K
Drug Distribution: Volume of Distribution01:25

Drug Distribution: Volume of Distribution

4.1K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosis.

Journal of hepatology·2026
Same author

Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective.

Gut·2026
Same author

United States Experience With Terlipressin in Hepatorenal Syndrome: Response, Mortality, and Transplant Outcomes - Results From the HRS Harmony Consortium.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Expedited assessment for liver transplantation in patients with alcohol-associated liver disease using the Dallas consensus framework.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Screening for liver disease in patients with diabetes: new standard of care?

Proceedings (Baylor University. Medical Center)·2026
Same author

Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis.

Hepatology communications·2026

Related Experiment Video

Updated: May 16, 2025

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
05:37

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Published on: October 20, 2023

1.2K

The liver allocation landscape: MELD 3.0 and continuous distribution.

Yeshika Sharma1, Connor Fischbach, Sumeet K Asrani

  • 1Baylor University Medical Center, Dallas, Texas, USA.

Current Opinion in Organ Transplantation
|April 2, 2025
PubMed
Summary

The new MELD 3.0 score and continuous distribution aim to improve liver transplant allocation. These advancements offer more personalized and equitable prioritization for patients awaiting transplants.

Keywords:
MELD 3.0continuous distributionorgan allocation

More Related Videos

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

12.7K
DUCT: Double Resin Casting followed by Micro-Computed Tomography for 3D Liver Analysis
12:39

DUCT: Double Resin Casting followed by Micro-Computed Tomography for 3D Liver Analysis

Published on: September 28, 2021

3.2K

Related Experiment Videos

Last Updated: May 16, 2025

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
05:37

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Published on: October 20, 2023

1.2K
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

12.7K
DUCT: Double Resin Casting followed by Micro-Computed Tomography for 3D Liver Analysis
12:39

DUCT: Double Resin Casting followed by Micro-Computed Tomography for 3D Liver Analysis

Published on: September 28, 2021

3.2K

Area of Science:

  • Hepatology and Transplant Surgery
  • Medical Ethics and Health Policy

Background:

  • The current liver organ allocation system faces challenges in efficiency and equity.
  • There is a growing need for improved prioritization of liver transplant candidates.

Purpose of the Study:

  • To review recent advancements in liver organ allocation.
  • To highlight the transition to Model for End-Stage Liver Disease (MELD) 3.0.
  • To discuss the potential introduction of continuous distribution in organ allocation.

Main Methods:

  • Review of current literature and proposed changes in liver allocation systems.
  • Analysis of the MELD 3.0 score and its components.
  • Examination of the principles and potential impact of continuous distribution.

Main Results:

  • MELD 3.0 refines the original MELD score by incorporating additional factors for more accurate prioritization.
  • Continuous distribution offers a dynamic allocation model integrating donor and recipient variables for nuanced decision-making.
  • These innovations aim to better assess disease severity and transplant urgency.

Conclusions:

  • MELD 3.0 and continuous distribution seek to enhance fairness and patient outcomes in liver transplantation.
  • Implementation challenges include technical complexities and regional disparities in access.
  • Ongoing evaluation is crucial to ensure equitable and effective application across diverse patient populations.